The present study investigated the synergistic effects of targeted methotrexate-selenium nanostructure containing Myc decoy oligodeoxynucleotides along with X-irradiation exposure and chemotherapy as a combinational therapy on LNCaP prostate cancer cells. The gene discussed is MYC; the disease is prostate carcinoma.